See the DrugPatentWatch profile for Escitalopram
Escitalopram: A Guide to Generic Manufacturers
Escitalopram, an SSRI antidepressant, has been widely prescribed for its efficacy in treating depression and anxiety disorders. The patent for one of the initial formulations, Cipralex, expired over a decade ago, allowing generic versions to enter the market. Here's an overview of the current landscape of escitalopram generic manufacturers.
How Does the Escitalopram Patent Expiration Affect Generic Availability?
The patent for escitalopram itself expired in 2012, but it's the specific formulations and dosages that are still protected by patents [1]. Some pharmaceutical companies have challenged these patents, which has led to disputes over generic versions of escitalopram.
Why Are Companies Challenging the Escitalopram Patents?
The main challenge is from the patent holders of Cipralex and other branded formulations. These companies claim that generic manufacturers are infringing on their intellectual property rights by producing similar products.
What are Some of the Generic Manufacturers Offering Escitalopram?
* Teva Pharmaceuticals has received FDA approval for its generic version of escitalopram, which is marketed under the name Teva-Escitalopram [2].
* Mylan and its partners have also launched a generic version of escitalopram.
* Other manufacturers, such as Aurobindo and Lupin, have also obtained FDA approval for their generic versions.
What Side Effects are Patients Asking About?
Escitalopram has been associated with various side effects, including nausea, dizziness, and headaches. The most commonly reported side effect is nausea, which affects about 10% of patients taking the medication.
How Does this Drug Compare with Other Antidepressants?
Escitalopram is generally well-tolerated and has a rapid onset of action. It is often compared to other SSRIs like fluoxetine (Prozac) and sertraline (Zoloft). The choice between these medications depends on individual patient needs and circumstances.
When Does Exclusivity Expire?
The exclusivity for the branded version of escitalopram, Cipralex, has expired. However, patents for specific formulations and dosages may still be in effect, which can limit competition from generic manufacturers.
Who Makes the Generic Version Available to Patients?
Generic manufacturers like Teva, Mylan, Aurobindo, and Lupin are working to make escitalopram available to patients at a lower cost.
References:
1. DrugPatentWatch.com. Retrieved 22 June 2026.
2. FDA News Release.